Literature DB >> 30816605

P53: The endothelium defender.

Mohammad Afaz Uddin1, Nektarios Barabutis1.   

Abstract

P53 represents the paradigm of a multitalented transcription factor, responsible for the cellular defense against a plethora of potentially harmful stimuli. It exercises the ability to strongly oppose both cancer and inflammation, partially due to the fact that both conditions are highly interrelated. Endothelium hyperpermeability is considered the hallmark of severe lung inflammation, and the cardinal feature of the lethal acute respiratory distress syndrome. An emerging body of evidence suggests a strategic role of P53 towards vascular barrier integrity. The "endothelium defender" orchestrates meticulously devised responses; to counteract toxin-induced destructions of endothelium monolayers. The present effort seeks to further our understanding on the expanding P53 universe, discussing the most recent information regarding the involvement of that molecule in the pulmonary function.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; inflammation; vascular biology

Year:  2019        PMID: 30816605      PMCID: PMC6713618          DOI: 10.1002/jcb.28511

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  27 in total

Review 1.  Aging, inflammation and cancer.

Authors:  Barbara Bottazzi; Elio Riboli; Alberto Mantovani
Journal:  Semin Immunol       Date:  2018-11-06       Impact factor: 11.130

2.  Phosphatase wild-type p53-induced phosphatase 1 controls the development of TH9 cells and allergic airway inflammation.

Authors:  Peng Wang; Huiting Su; Lianjun Zhang; Hui Chen; Xuelian Hu; Fan Yang; Jun Lv; Lianfeng Zhang; Yong Zhao
Journal:  J Allergy Clin Immunol       Date:  2017-07-19       Impact factor: 10.793

3.  p53 protects against LPS-induced lung endothelial barrier dysfunction.

Authors:  Nektarios Barabutis; Christiana Dimitropoulou; Charalampos Birmpas; Atul Joshi; Gagan Thangjam; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

Review 4.  Regulation of pulmonary endothelial barrier function by kinases.

Authors:  Nektarios Barabutis; Alexander Verin; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

5.  MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53: MicroRNA-150 in CS-induced lung inflammation.

Authors:  H Xue; M X Li
Journal:  Hum Exp Toxicol       Date:  2017-12-05       Impact factor: 2.903

6.  Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation.

Authors:  Nektarios Barabutis; Mohammad A Uddin; John D Catravas
Journal:  Cytokine       Date:  2018-11-09       Impact factor: 3.861

7.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

8.  Bevacizumab induces inflammation in MDA-MB-231 breast cancer cell line and in a mouse model.

Authors:  Layal El-Hajjar; Nour Jalaleddine; Abdullah Shaito; Kazem Zibara; Jalal M Kazan; Jamal El-Saghir; Marwan El-Sabban
Journal:  Cell Signal       Date:  2018-11-14       Impact factor: 4.315

9.  P53 mediates lipopolysaccharide-induced inflammation in human gingival fibroblasts.

Authors:  Jia Liu; Jiajun Zeng; Xiaoxuan Wang; Ming Zheng; Qingxian Luan
Journal:  J Periodontol       Date:  2018-08-14       Impact factor: 6.993

Review 10.  P53, GHRH, inflammation and cancer.

Authors:  Nektarios Barabutis; Andrew V Schally; Agnieszka Siejka
Journal:  EBioMedicine       Date:  2018-10-19       Impact factor: 8.143

View more
  12 in total

1.  P53 supports endothelial barrier function via APE1/Ref1 suppression.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Agnieszka Siejka; John D Catravas; Nektarios Barabutis
Journal:  Immunobiology       Date:  2019-04-18       Impact factor: 3.144

2.  GHRH antagonists support lung endothelial barrier function.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Sitanshu S Singh; Khadeja-Tul Kubra; Andrew V Schally; Seetharama Jois; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2019-10-03

Review 3.  Unfolded Protein Response supports endothelial barrier function.

Authors:  Nektarios Barabutis
Journal:  Biochimie       Date:  2019-08-09       Impact factor: 4.079

4.  Unfolded protein response in endothelial injury.

Authors:  Nektarios Barabutis
Journal:  Cell Cycle       Date:  2022-05-26       Impact factor: 5.173

5.  A glimpse at growth hormone-releasing hormone cosmos.

Authors:  Nektarios Barabutis
Journal:  Clin Exp Pharmacol Physiol       Date:  2020-04-25       Impact factor: 2.557

6.  P53 Regulates the Redox Status of Lung Endothelial Cells.

Authors:  Mohammad S Akhter; Mohammad A Uddin; Nektarios Barabutis
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

7.  Effects of Heat Shock Protein 90 Inhibition In the Lungs.

Authors:  Mohammad A Uddin; Khadeja-Tul Kubra; Jafrin Jobayer Sonju; Mohammad S Akhter; Jois Seetharama; Nektarios Barabutis
Journal:  Med Drug Discov       Date:  2020-05-17

8.  P53 in lung vascular barrier dysfunction.

Authors:  Nektarios Barabutis
Journal:  Vasc Biol       Date:  2020-05-20

9.  P53 deficiency potentiates LPS-Induced acute lung injury in vivo.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Khadeja-Tul Kubra; Nektarios Barabutis
Journal:  Curr Res Physiol       Date:  2020-07-09

10.  Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Khadeja-Tul Kubra; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.